# Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

> **NCT04883827** · — · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 180 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **OTHER:** Blood collection
- **OTHER:** Urine collection

## Key facts

- **NCT ID:** NCT04883827
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-06
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883827, "Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04883827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*